...
首页> 外文期刊>Bioethics >Disputing the ethics of research: The challenge from bioethics and patient activism to the interpretation of the declaration of helsinki in clinical trials
【24h】

Disputing the ethics of research: The challenge from bioethics and patient activism to the interpretation of the declaration of helsinki in clinical trials

机译:反对研究伦理学:从生物伦理学和患者行动主义到临床试验中对赫尔辛基宣言的解释的挑战

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this paper we argue that the consensus around normative standards for the ethics of research in clinical trials, strongly influenced by the Declaration of Helsinki, is perceived from various quarters as too conservative and potentially restrictive of research that is seen as urgent and necessary. We examine this problem from the perspective of various challengers who argue for alternative approaches to what ought or ought not to be permitted. Key themes within this analysis will examine these claims and argue they have implications for the interests of the research subject, research governance and regulation. Using our work with TREAT-NMD, the neuromuscular clinical trials network, we posit that there is a place for advancing the discourse of moral rights and moral duties in the context of research, especially from the perspective of patients and their families, and for including the politics of patient activism and empowerment. At the same time we remain vigilant to the danger that the therapeutic misconception and other serious vulnerabilities for the patient population in clinical trials, are at risk of being overlooked.
机译:在本文中,我们认为,在赫尔辛基宣言的强烈影响下,围绕临床试验研究道德规范标准的共识在各个方面都被认为过于保守和潜在地限制了研究,认为这是紧迫和必要的。我们从各种挑战者的角度研究了这个问题,他们提出了关于应允许或不应允许的替代方法的主张。本分析中的关键主题将研究这些主张,并认为它们对研究主题,研究治理和法规的利益具有影响。利用我们与神经肌肉临床试验网络TREAT-NMD的合作,我们认为在研究的背景下,尤其是从患者及其家人的角度出发,存在着促进道德权利和道德义务论述的地方,包括患者行动主义和授权政治。同时,我们仍然警惕在临床试验中对患者群体的治疗错误观念和其他严重脆弱性有被忽视的危险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号